07:00 , Jun 22, 2009 |  BC Week In Review  |  Company News

Hebrew University of Jerusalem deal

Investment group Aurum Ventures MKI Ltd. received an option from the university's Yissum Research and Development Ltd. to license an oral reformulation of an undisclosed injectable drug that uses Yissum's nanotechnology controlled-release drug delivery technology....